Kylian Mbappé has made a significant investment in Alan, a French health insurance startup, through his Coalition Capital fund. This move was part of a €100 million funding round that valued Alan at €5 billion. The exact amount of Mbappé's stake has not been publicly disclosed, but it has been described as "significant" by Alan CEO Jean-Charles Samuelian.
Beyond the financial investment, Mbappé will also serve as an ambassador for Alan. His role includes helping to develop new health-focused features on the platform, such as fitness challenges, wellness content, and personalized recommendations aimed at increasing user engagement with their well-being. This investment further solidifies Mbappé's presence in the tech and innovation sectors, building on his existing involvement with the fantasy football platform Sorare.
Alan, founded in France, has expanded its operations to Spain, Belgium, and Canada. The company reported €785 million in annual recurring revenue (ARR) in 2025, up from €505 million the previous year, and is targeting €1 billion for 2026. It serves approximately 1.1 million users and has achieved profitability in France, with group-level profitability expected by 2027. The company's recent acquisition of preventive health startup Aro indicates its move into direct-to-consumer diagnostics.
Simultaneously, another healthtech company, Eyone, based in Senegal, has secured substantial funding of approximately $3 million (1.7 billion CFA francs) from Oyass Capital. This funding is specifically tied to the rollout of Senegal's Shared Single Patient Record (DPUP), a government initiative to centralize and digitize medical data nationwide. Eyone's platform aims to replace traditional paper medical records with a unified digital profile accessible to authorized practitioners, addressing issues like repeated lab tests and delays caused by manual data entry in Francophone Africa.
Mbappé's investment in Alan highlights a growing trend of elite athletes diversifying their portfolios and becoming active participants in the companies they back. This approach offers challenger brands not just reach, but also alignment of incentives, potential for co-development, and genuine product integration, allowing athletes to embed the brand into their daily lives rather than just endorse it.
